Chien-Chung Lin

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Venues

Thoracic cancer

Biomedicines

International journal of environmental research and public health

Cancers

National Cheng Kung University

National Cheng Kung University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cheng Kung University

Taiwan

Associate professor :: Department of Internal Medicine

Education History

National Cheng Kung University Aug 01 2005 - Feb 15 2011

Taiwan

PHD :: Graduate Institute of Clinical Medicine

Publications

Chin-Wei Kuo, Chien-Yu Lin, Sheng-Huan Wei, Yun-Tse Chou, Chian-Wei Chen, Jeng-Shiuan Tsai, Po-Lan Su, Chien-Chung Lin
Navigating the challenges of invasive pulmonary aspergillosis in lung cancer treatment: a propensity score study. Therapeutic advances in medical oncology 15 (2023)
Chien-Yu Lin, Chia-Hao Hu, Chia-Fu Hsu, Jeng-Shiuan Tsai, Chian-Wei Chen, Chia-Yin Lin, Chao-Chun Chang, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Chien-Chung Lin
Chemotherapy outcomes in EGFR-TKI resistant patients with common and uncommon EGFR mutation: An exploratory retrospective cohort study. Thoracic cancer (2023)
Jeng-Shiuan Tsai, Sheng-Huan Wei, Chian-Wei Chen, Szu-Chun Yang, Yau-Lin Tseng, Po-Lan Su, Chien-Chung Lin, Wu-Chou Su
Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)
Po-Lan Su, Jung-Yueh Chen, Chang-Yao Chu, Yi-Lin Chen, Wan-Li Chen, Kuan-Yu Lin, Chung-Liang Ho, Jeng-Shiuan Tsai, Szu-Chun Yang, Chian-Wei Chen, Yi-Lin Wu, Yau-Lin Tseng, Chao-Chun Chang, Yi-Ting Yen, Chia-Ying Lin, Chien-Chung Lin, Wu-Chou Su
The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy. Scientific reports 12 (1) (2022)
Szu-Chun Yang, Ching-Han Lai, Chin-Wei Kuo, Chien-Chung Lin, Wu-Wei Lai, Jung-Der Wang
Downstream Complications and Healthcare Expenditure after Invasive Procedures for Lung Lesions in Taiwan. International journal of environmental research and public health 18 (8) (2021)
Chien-Chung Lin, Chin-You Wu, Joseph T Tseng, Chun-Hua Hung, Shang-Yin Wu, Yu-Ting Huang, Wei-Yuan Chang, Po-Lan Su, Wu-Chou Su
Extracellular Vesicle miR-200c Enhances Gefitinib Sensitivity in Heterogeneous EGFR-Mutant NSCLC. Biomedicines 9 (3) (2021)
Sheng-Yuan Wang, Ching-Han Lai, Chian-Wei Chen, Szu-Chun Yang, Chao-Chun Chang, Chia-Ying Lin, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Chien-Chung Lin, Wu-Chou Su
Improved survival in patients with unresectable stage III EGFR-mutant adenocarcinoma with upfront EGFR-tyrosine kinase inhibitors. Thoracic cancer (2021)
Feng Li, Fang Wei, Wei-Lun Huang, Chien-Chung Lin, Liang Li, Macy M Shen, Qingxiang Yan, Wei Liao, David Chia, Michael Tu, Jason H Tang, Ziding Feng, Yong Kim, Wu-Chou Su, David T W Wong
Ultra-Short Circulating Tumor DNA (usctDNA) in Plasma and Saliva of Non-Small Cell Lung Cancer (NSCLC) Patients. Cancers 12 (8) (2020)
Po-Lan Su, Szu-Chun Yang, Yi-Lin Chen, Yi-Lin Wu, Chia-Ying Lin, Wei-Yuan Chang, Yau-Lin Tseng, Wu-Wei Lai, Chung-Liang Ho, Chien-Chung Lin, Wu-Chou Su
Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment. Cancer medicine 8 (13) (2019)
Wei-Yuan Chang, Yi-Lin Wu, Po-Lan Su, Szu-Chun Yang, Chien-Chung Lin, Wu-Chou Su
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis. PloS one 13 (2) (2018)

Chien-Chung Lin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Chien-Chung Lin